Skip to main content

Table 1 Participants’ demographic and clinical characteristics (n = 42)

From: Haemodynamic determinants of quality of life in chronic heart failure

Age (years) 60 ± 10
Male/female (%) 74/26
Weight (kg) 88 ± 15
Height (m) 1.73 ± 0.07
BMI (kg/m2) 29 ± 4
Functional class (NYHA) II/III 19/23
LVEF (%) 23 ± 7
MLHF 40 ± 23
Aetiology (IHD/DCM/Others) 22/14/6
AF 14
ICD 19
Medication; n (%)
ACE inhibitors 27 (64)
β-blockers 41 (98)
ARBs 9 (21)
Diuretics 33 (78)
MRA 27 (64)
Anti-arrhythmic 14 (33)
NSAID/analgesic 12 (28)
Antiplatelet/anticoagulant 17 (40)
ARNI 4 (9)
  1. ACE angiotensin converting enzyme, AF atrial fibrillation, ARB angiotensin receptor blockers, ARNI angiotensin receptor neprilysin inhibitor, DCM dilated cardiomyopathy, IHD ischaemic heart disease, LVEF left ventricular ejection fraction, MLHF Minnesota living with heart failure, MRA mineralocorticoid receptor antagonist, NYHA New York Heart Association, NSAID non-steroid anti-inflammatory drugs